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Abstract: We have isolated the rat ortholog of EFP1 (EF-hand binding protein 1) as a novel 
interaction partner of the pro-apoptotic protein Par-4 (prostate apoptosis response-4). Rat EFP1 
contains two thioredoxin domains, the COOH-terminal one harboring a CGFC motif, and has 
a similar protein domain structure as members of the protein disulfide isomerase (PDI) family. 
In REF52.2 and CHO cells, EFP1 colocalized with the endoplasmic reticulum (ER) marker 
PDI. Furthermore, EFP1 possesses catalytic activity as demonstrated by an insulin disulfide 
reduction assay. Western blot analysis revealed two EFP1 protein bands of approximately 
136 and 155 kDa, representing different glycosylation states of the protein. Complex forma-
tion between EFP1 and Par-4 was confirmed in vitro and in vivo by co-immunoprecipitation, 
dot blot overlay and pull-down experiments. In CHO cells, coexpression of EFP1 and Par-4 
resulted in enhanced Par-4-mediated apoptosis, which required the catalytic activity of EFP1. 
Interestingly, EFP1 was specifically upregulated in NIH3T3 cells after induction of ER stress 
by thapsigargin, tunicamycin, and brefeldin A, but not by agents that induce oxidative stress 
or ER-independent apoptosis. Furthermore, we could show that the induction of apoptosis by 
Ca2+ stress-inducing agents was significantly decreased after siRNA oligonucleotide-mediated 
knockdown of  Par-4. Our data suggest that EFP1 might represent a cell-protective enzyme that 
could play an important role in the decision between survival and initiation of Par-4-mediated 
apoptosis.
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Introduction
Conditions that alter the endoplasmic reticulum (ER) environment, commonly 
referred to as ER stress, can affect the efficiency of ER enzymes in performing their 
multiple tasks like protein folding and glycosylation. For example, extraordinarily 
high protein synthesis rates, as they occur in a virus-infected cell, can lead to an 
ER overload and to an accumulation of misfolded or unfolded proteins in the ER. 
Likewise, deregulated calcium homeostasis can disturb the function of the ER. In 
order to overcome such situations, genetic and molecular programs are activated 
to restore the function of the ER. A typical ER stress response initially consists of 
the attenuation of translation and activation of protein degradation pathways, while 
simultaneously the specific ER stress transcription factor ATF6 is activated,1–3 which 
upregulates genes for ER chaperones like protein disulfide isomerase (PDI) and 
glucose-regulated protein 78/immunoglobulin binding protein (GRP78/BiP) to cope 
with the enhanced protein charge.4,5 Many stress-inducible ER chaperones, including 
PDI, glucose-regulated protein 94 (GRP94) and GRP78/BiP, also contain calcium Cell Health and Cytoskeleton 2009:1 
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binding domains that help maintaining or restoring the 
calcium gradient between the ER and the cytoplasm.6–8
However, when the ER stress response fails to overcome 
the situation, signaling pathways are activated that induce 
execution of the programmed cell death, apoptosis.9 To 
date, two major ER-specific apoptotic pathways are known. 
One of them initiates apoptosis by activation of caspases, 
cysteine-aspartate proteinases that play a central role in 
apoptosis.10 Caspase-12 and caspase-4 have been described 
as ER-specific caspases that are activated during persistent 
ER stress.11,12 In addition, participation of other caspases has 
been suggested.13,14 A recent publication has demonstrated 
the dispensability of caspase-4 and caspase-12 for caspase-
dependent ER stress-mediated apoptosis,15 suggesting the 
participation of other caspases. Thus, multiple redundant 
pathways may lead from ER stress to caspase-activation. 
ER stress-induced apoptosis can also be initiated indepen-
dently of caspases, since an alternative apoptotic pathway 
in ER stress is triggered by GADD153/CHOP, an ER stress-
inducible transcription factor.16 GADD153/CHOP alters the 
balance between the anti-apoptotic protein Bcl-2 and the 
pro-apoptotic Bax,17 resulting in cytochrome C release from 
the mitochondria, a highly conserved pathway of apoptosis 
induction.18
One of the proteins that has been implicated in ER 
stress-dependent apoptotic processes is the pro-apoptotic 
protein Par-4 (prostate apoptosis response-4).19 The protein 
was originally discovered as the product of an early response 
gene in ionomycin-induced apoptosis of prostate cancer 
cells.20 The mechanisms how Par-4 can induce or support 
apoptotic processes are versatile. We have demonstrated that 
Par-4 can bind to actin filaments and can induce apoptosis 
by sequestering nuclear proteins to the cytoskeleton like 
the pro-apoptotic serine/threonine kinase Dlk/ZIPK or the 
pro-apoptotic protein Amida.21–23 In other cellular settings, 
Par-4 can act as a transcriptional co-repressor of the bcl-2 
gene,24 or as an inhibitor of PKB/Akt.25 However, many 
aspects of Par-4-mediated apoptosis are still poorly under-
stood. In an effort to identify novel interaction partners of 
Par-4 that might serve as regulators or downstream effectors 
in Par-4-mediated apoptosis, we identified the rat ortholog 
of EF-hand binding protein 1 (EFP1) in a yeast two-hybrid 
screen. EFP1 was previously identified as an interaction 
partner of Duox, a protein involved in H2O2 production in the 
thyroid.26 We show that EFP1 is an ER-resident glycoprotein 
which possesses enzymatic activity in an insulin reduction 
assay and demonstrate that EFP1 is upregulated during ER 
stress. Coexpression of EFP1 and Par-4 resulted in enhanced 
EFP1/Par-4-mediated apoptosis, suggesting that EFP1 can 
trigger Par-4-mediated apoptosis.
Materials and methods
generation of the cDnA library  
and yeast two-hybrid screening
The generation of the cDNA library and the yeast two-hybrid 
screening have been described previously.27 Briefly, 
poly(A)+ RNA was isolated from TZ103 cells, reverse-
transcribed, and inserted into the HybriZAP™ vector28 
using the ZAPExpress™ cDNA synthesis kit (Stratagene, 
La Jolla, CA). Two-hybrid screening was performed with 
Par-4 fused to the GAL4 DNA binding domain as bait. His 
and lacZ-positive clones were isolated and the cDNA inserts 
were further analyzed by cloning and sequencing.
Cloning of rat eFP1 cDnA  
and construction of plasmids
The rat EFP1 cDNA was amplified by RT-PCR using 
the E14-2 cDNA as template and the oligonucleotides 
5´-GAAGGTCAAGTATCCAGGAGGCTGG-3´ and 
5´-CCCAAGCTTATGTCGGAATGCGGA-3´ derived 
from the rat sequence EST XM220122.2. A C-terminally 
GFP-tagged full-length EFP1 cDNA construct (denoted 
EFP1-GFP) was generated by PCR with oligonucleotides 
5´-CGGGATCCTGATGGCGCGCCAG-3´  and 
5´-GCGGATCCAGTAAGTCTGTCCTGTTCTC-3´ 
and subcloned into the pEGFP-N1 expression vector 
using BamHI restriction sites (Clontech, Heidelberg, 
Germany). In order to generate a thioredoxin-domain 
II mutant of EFP1 (denoted EFP1THX-) in which the 
cysteine residues of the CXXC motif were replaced by 
serines, site-directed mutagenesis was performed with 
the oligonucleotide pairs 5´-GAGTTTGCCACAATT-
GTCGATGTG-3´, 5´-AGATGGGCTAAAGCCACTC-
CACTG-3´, 5´-CAGTGGAGTGGCTTTAGCCCATCT-3´ 
and 5´-CCACCGGTGCTAAGTCTGTCCTGTTCTC-3´. 
A HindIII/BamHI cDNA restriction fragment of EFP1 was 
subcloned into the pcDNA6/Myc-His C vector (Invitrogen) 
to generate the construct EFP1-Myc. For the N-terminally 
His-tagged Par-4 cDNA construct (denoted His6-Par-4), the 
EcoRI fragment of the Par-4 cDNA from pCB6+-Par-429 
was subcloned into the pPROEXTM HTa expression vector 
(Invitrogen GmbH, Karlsruhe, Germany). The construction 
of FLAG-Par-4 and the leucine zipper mutants FLAG-Par-4 
L3A and His6-Par-4 L3A, carrying exchanges of leucines 295, 
316, and 330 to alanines, has been described previously.21,23Cell Health and Cytoskeleton 2009:1 
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RnA expression analysis by northern 
blotting and RT-PCR
A blotting membrane containing ∼2 µg of poly(A)+ RNA 
per lane from eight different rat tissues (Clontech) was 
used for Northern analysis. The filter was hybridized 
with a [α-32P]dCTP-labeled EFP1 cDNA-fragment and 
with a [α-32P]dCTP-labeled glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH) probe. Densiometric analysis 
of EFP1 and GAPDH expression was performed using 
ImageJ software (National Institutes of Health, Bethesda, 
MD, USA). For reverse transcriptase-polymerase chain 
reaction (RT-PCR) analysis, total RNA from various 
cultured cell lines (REF52.2, PC3, C6, E14-2, TZ102, 
TZ103, TZ107, N2A and NIH3T3) was prepared using the 
TRIzol® reagent (Invitrogen) according to the manufacturer’s 
recommendations. In some experiments, the cells were treated 
with DMSO (0.72% for 24 h), ionomycin (10 µM for 24 h), 
tunicamycin (3 µM for 24 h), thapsigargin (4 µM for 24 h), 
brefeldin A (35.7 µM for 24 h), H2O2 (1 mM for 24 h) or 
staurosporine (10 nM for 16 h) prior to preparation of RNA. 
RNA (2.5 µg) was reverse transcribed by SuperScript II® 
Reverse Transcriptase (Invitrogen) using a 17mer oligo-dT 
primer. Expression of EFP1 was analyzed by PCR with 
oligonucleotides 5´-CCCCATGAGTGCTGTTTACATT-3´ 
and 5´-CGTACTGTTCCTAGGTAATC-3´ amplifying a 
219 bp product of EFP1 and expression of GRP78/BiP with 
oligonucleotides 5´-GAAAGGATGGTTAATGATGCTGAG-
3´ and 5´-GTCTTCAATGTCCGCATCCTG-3´ amplifying 
a 231 bp GRP78/BiP product. As internal control, a 309 bp 
GAPDH product was amplified with the oligonucleotides 
5´-CGGTGTGAACGGATTTGGCCGTAT-3´ and 5´-
AGCCTTCTCCATGGTGGTGAAGAC-3´.
Computer-assisted sequence analysis
To analyze the EFP1 structure in detail, multiple sequence 
alignments were performed with the ClustalW program.30 
For secondary structure predictions, the PredictProtein31 and 
the Paircoil programs32 were employed and the analyses of 
intracellular localization, posttranslational modifications, 
and signal peptide predictions were performed with the 
PSORT II,33 NetPhos,34 NetNGlyc, and SignalP programs.35
Cell culture and transfection
Rat embryo fibroblast line REF52.2, rat fetal brain cell line 
E14-2, human cervical carcinoma cell line HeLa, rat glioma 
cell line C6, rat PNET cell lines TZ102, TZ103 and TZ107 and 
green monkey kidney fibroblast cell line COS-1 were main-
tained in Dulbecco’s modified Eagle medium (DMEM; 
Sigma, Deisenhofen, Germany) supplemented with 10% 
fetal calf serum (FCS; PAA Laboratories, Vienna, Austria). 
Human prostate cancer cell line PC3 was cultured in RPMI 
supplemented with 10% FCS. Mouse neuroblastoma cell line 
N2A was maintained in modified Eagle’s medium (MEM; 
PromoCell, Heidelberg, Germany) supplemented with 10% 
FCS, 1% glutamine and 1% nonessential amino acids (Sigma). 
Hamster ovarian cells (CHO) were grown in Nutrient Mix-
ture F12 (Sigma) with 10% FCS. Mouse immortal fibroblast 
cell line NIH3T3 was cultured in DMEM high glucose 
(Sigma) with 10% FCS and 1% glutamine. All cell culture 
media were supplemented with 100 units/ml penicillin and 
100 µg/ml streptomycin. For transfection experiments, cells 
were seeded at 1000–3000 cells per mm2 and transiently 
transfected using the jetPEI transfection reagent (PolyPlus, 
Illkirch, France) according to the manufacturer’s protocol. 
For the generation of stable EFP1-expressing cell lines, CHO 
cells were transfected with EFP1-GFP expression vector 
and selected in the presence of 1 µg/ml Geneticin (G418) 
(Life Technologies, Inc, Karlsruhe, Germany). EFP1-GFP 
expressing colonies were selected and further cultured. 
For the Par-4 siRNA experiments, cells were transiently 
transfected with 20 pmol of Cy3-labeled 21-nucleotide 
double-stranded RNA molecules (Perbio Science Germany, 
Bonn) using the Lipofectamine 2000 reagent (Invitrogen) 
according to manufacturer’s protocol. The following Par-
4 siRNA oligonucleotides were employed: human Par-4 
sense 5´-Cy3-GAUGCAAUUACACAACAG AUU-3´ 
and human Par-4 antisense 3´-UUCUACGUUAAUGU-
GUUGUCU-Cy3-5´.36 As mismatch control, siRNA oli-
gonucleotides against rat Par-4 were used: rat Par-4 sense 
5´-Cy3-GAUGCUAUCACACAGCAGAUU-3´ and rat 
Par-4 antisense 3´-UUCUACGAUAGUGUGUCGUCU-
Cy3-5´. 48 h after transfection the cells were examined by 
fluorescence microscopy.
Immunofluorescence analysis
For immunofluorescence analysis, transfected cells were 
fixed with 3% paraformaldehyde and stained with the mouse 
monoclonal anti-c-Myc antibody 9E10 (1:200; Biomol 
GmbH, Hamburg, Germany), the rabbit polyclonal anti-
Par-4 antibody (1:5000; Santa Cruz Biotechnology Inc.) 
and the rabbit polyclonal anti-PDI antibody (1:4000, 
Biomol). As secondary antibodies, Cy3-conjugated goat 
anti-mouse IgG, Alexa488-conjugated goat anti-rabbit IgG 
and Cy3-conjugated goat anti rabbit IgGs (1:1000; Dianova, 
Hamburg, Germany) were used. Nuclei were stained with 
4,6-diamidino-2-phenylindole (DAPI). Cells were examined Cell Health and Cytoskeleton 2009:1 
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with an Axiophot fluorescence microscope (Carl Zeiss 
GmbH, Oberkochen, Germany) equipped with a CCD camera 
using filters optimized for double-label experiments and a 
63 × oil immersion objective. Confocal microscopy was 
performed with a Zeiss Axioplan fluorescence microscope 
coupled with a Zeiss LSM510. Images were processed with 
Adobe photoshop 7.0 software.
Protein expression and purification
His6-Par-4, His6-Par-4 L3A, His6-EFP1 and His6-Amida were 
expressed in the E. coli strain BL21-CodonPlus DE3 (Strata-
gene). Bacteria were transformed with either expression 
vector and grown in LB-medium at 37 °C. Protein expres-
sion was induced in late log phase with 1 mM isopropyl-1-
thio-β-D-galactopyranoside (IPTG) at 20–25 °C. Bacteria 
were harvested 5 h after induction and resuspended in 
NiNTA-buffer (50 mM KPO4-buffer, pH 8.0, 500 mM KCl, 
10 mM imidazole, 5 mM 2-mercaptoethanol, 0.2% Tween, 
1 mM PMSF). The cells were lysed with 1 mg/ml lysozyme 
for 15 min at 4 °C in the presence of 2 units/ml Benzonase 
(Merck Biosciences GmbH, Schwalbach, Germany). Lysates 
were solubilized by ultrasonic disruption and cleared from 
cell debries by centrifugation. Recombinant proteins were 
purified using a NiNTA-matrix (IBA GmbH, Göttingen, 
Germany) essentially according to the manufacturer’s 
instructions. The samples were further purified on a NAP-5 
column (Amersham), eluted in low salt buffer (20 mM Tris 
pH 7.0, 20 mM KCl) and concentrated on a Centricon 
Centrifugal Filter Unit with Ultracel YM-10 membrane 
(Millipore GmbH, Schwalbach, Germany).
sDs-PAge, Western Blot analysis  
and dot blot immunoassay
Cells were lysed in isotonic lysis buffer (10 mM NaPO4, pH 
8.0, 140 mM NaCl, 3 mM MgCl2, 1 mM dithiothreitol, 0.5% 
Nonidet-P40 and 50 µM leupeptin). The cell lysates were 
subjected to SDS-PAGE according to standard procedures 
and electrophoretically transferred onto nitrocellulose mem-
branes (Schleicher and Schuell GmbH, Dassel, Germany). The 
membranes were stained either with the mouse monoclonal 
anti-GFP antibody (1:2000, Clontech), the mouse monoclonal 
anti-FLAG M2 antibody (1:5000, Invitrogen), the rabbit 
polyclonal (1:5000) and mouse monoclonal (1:2000) anti-
Par-4 antibodies (Santa Cruz Biotechnology Inc., Heidelberg, 
Germany) or the mouse monoclonal anti-α-Tubulin anti-
body DM 1A (1:5000, Sigma). Bound antibodies were 
detected with peroxidase-conjugated secondary goat anti-
mouse or goat anti-rabbit IgGs (1:5000, Dianova) using 
a SuperSignal® West Pico chemoluminescence detection 
kit (Perbio Science GmbH, Bonn, Germany). For dot blots, 
10–250 ng of purified recombinant His6-Amida protein, His6-
EFP1 protein and bovine serum albumine (BSA) were spotted 
onto nitrocellulose membranes (Schleicher and Schuell). 
After blocking, membranes were incubated with 3 µg/ml of 
purified recombinant His6-Par-4 or His6-Par-4 L3A protein 
for 2 h and further processed as described above.
Insulin disulfide reduction assay
The assay was performed essentially as described by 
Holmgren37 in quartz cuvettes in a final volume of 120 µl. 
Briefly, the incubation mixtures contained 3.9 µM of purified 
recombinant His6-EFP1 protein, His6-EFP1THX-protein or 
recombinant thioredoxin protein from E. coli (Sigma), 0.1 M 
potassium phosphate (pH 7.0), 2 mM EDTA and 0.13 mM of 
bovine insulin (Sigma). The reaction was started by adding 
0.33 mM dithiothreitol to the mixture. The rate of insulin 
reduction was measured spectrophotometrically at 650 nm 
for 100 min as turbidity formation from the precipitation of 
the insoluble free B chain.
In vitro translation and pulldown assay
In vitro translated [35S]-methionine labeled EFP1 was 
generated with the TNT-coupled reticulocyte lysate system 
(Promega GmbH, Mannheim, Germany) using the EFP1-
Myc vector as template according to the manufacturer’s 
protocol. The labeled EFP1 protein was incubated for 30 min 
at 4 °C with NiNTA beads in the absence or in the presence 
of purified His6-Par-4 wt or His6-Par-4 L3A, respectively. 
After washing with pull-down buffer (50 mM KPO4-buffer 
pH 7.0, 5 mM MgCl2, 100 mM KCl, 10 mM imidazole, 5% 
glycerol, 0.2% Tween, 1 mM PMSF), the bound proteins 
were eluted from the NiNTA beads with pull-down buffer 
containing 500 mM KCl. The eluted proteins were separated 
by SDS-PAGE and analyzed by autoradiography.
immunoprecipitation and endoglycosidase 
H treatment
CHO cells stably expressing EFP1-GFP were transfected 
with FLAG-Par-4 or FLAG-vector alone as control. 24 h 
post-transfection, the cells were metabolically labeled 
with 250 µCi of [35S]methionine (10 mCi/ml, Amersham) 
per 9 cm-culture dish in methionine-free DMEM for 
2 h. After labeling, the cells were washed with ice-cold 
phosphate-buffered saline (PBS) and lysed in isotonic lysis 
buffer. The lysates were subjected to immunoprecipitation 
with the rabbit polyclonal anti-GFP antibody (Clontech). Cell Health and Cytoskeleton 2009:1 
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The antigen-antibody complexes were adsorbed to Protein 
A-Sepharose (Sigma), separated on 10% SDS-PAGE and 
further analyzed by autoradiography. For Endoglycosi-
dase H (EndoH) experiments, HeLa cells were transfected 
with EFP1-GFP. 24 h after transfection cells were lysed 
in isotonic lysis buffer and the cell lysates subjected to 
immunoprecipitation as described above. The antigen-anti-
body-sepharose complex was treated with 1x denaturation 
buffer (0.5% SDS, 1% β-mercaptoethanol) at 100 °C for 
10 minutes. The sepharose beads were sedimented and the 
supernatants were treated with EndoH (NEB) at 37 °C for 
1 h according to the manufacturer’s protocol. The samples 
were separated on 7.5% SDS-PAGE and further analyzed 
by Western blotting.
Apoptosis assay
CHO cells were co-transfected with FLAG-Par-4, EFP1-GFP 
and EFP1THX--GFP or with empty FLAG or GFP vectors as 
controls. 48 h post-transfection, the cells were fixed with 
paraformaldehyde, stained with the mouse monoclonal anti-
FLAG M2 antibody and with DAPI to visualize nuclei. For 
Par-4 knockdown experiments, HeLa cells were transfected 
with either human Par-4 siRNA or as mismatch control with 
rat Par-4 siRNA oligonucleotides. After transfection, the 
cells were treated either with ionomycin (10 µM for 24 h), 
thapsigargin (2 µM for 24 h), tunicamycin (3 µM for 24 h), 
etoposide (17 mM for 24 h), staurosporine (200 nM for 5 h) or 
with DMSO as a control (0.72 % for 24 h). After fixation with 
formaldehyde, the cells were stained for endogenous Par-4 
with the rabbit polyclonal anti-Par-4 antibody (Santa Cruz 
Biotechnology Inc.) and with DAPI to visualize nuclei. The 
percentage of apoptotic cells that showed fragmented nuclei, 
condensed chromatin and membrane blebbing was detected 
among the transfected cells by fluorescence microscopy, 
counting 100 to 200 EFP1/Par-4 positive cells or 100 to 200 
Par-4-knockdown cells versus Par-4 positive cells in the 
siRNA experiments in each experiment. Data were collected 
from five independent experiments, and the significance 
was determined in a one-tailed paired t-test for EFP1/Par-4 
co-transfection experiments, and a two-tailed paired t-test 
for Par-4 siRNA transfection experiments.
Results
Molecular cloning and sequence  
analysis of rat eFP1
In an attempt to identify new interaction partners of Par-4, 
we screened a rat cDNA library derived from the PNET cell 
line TZ10327,38 with full length Par-4 as bait. Seven positive 
clones were identified from histidine negative plates which 
were also positive for β-galactosidase expression. Sequence 
analysis revealed one clone with 100% identity to the rat 
cDNA XM220122.2, and BLAST analyses showed 94% 
and 90% sequence identity with the murine and human 
TXNDC11 (thioredoxin domain containing 11) cDNA 
sequences, encoding the EFP1.26 Thus, our isolated cDNA 
clone comprising an open reading frame for 947 amino acids 
represented the rat ortholog of TXNDC11/EFP1.
Computer-assisted analysis of the EFP1 amino acid 
sequence (see Materials and methods) revealed that the 
predicted protein contains an N-terminal ER signal sequence 
or signal anchor sequence (aa 54–83) but no ER retention 
signal, a putative transmembrane domain (aa 60–76, 
see Figure 1A), a putative NLS (aa 849–865), a leucine 
zipper motif (aa 834–855), an arginine rich sequence 
(aa 814–850), several putative phosphorylation sites for 
protein kinase C (PKC) and casein kinase 2 (CK2) as well 
as several N-glycosylation sites. The N-terminal portion of 
EFP1 is rich in glycine (35%, distributed between aa 5–50), 
thus facilitating N-myristoylation and a putative membrane 
localization of the protein. The presence of two thioredoxin 
domains (Figure 1A, a, aa 104–207 and a’, aa 659–764), 
whereas the C-terminal one contains a putative catalytically 
active CXXC motif (787CGFC790), classifies the protein as 
a novel member of the thioredoxin-related family. To gain 
more information about the domain structure of EFP1, the 
α-helix/β-strand composition was analyzed using the Predict-
Protein analysis program. Three variations of the thioredoxin 
fold alpha/beta pattern β-α-β-α-β-α-β-β-α39,40 were identi-
fied, two of them spanning the two thioredoxin domains a 
and a’, the other one adjacent to the first thioredoxin domain 
(b, Figure 1A).
eFP1 is expressed in various  
tissues and cell lines
To analyze the expression of EFP1 at the transcriptional 
level, we hybridized a multiple tissue Northern blot with a 
probe corresponding to the EFP1 nucleotides 1583–2170. 
As depicted in Figure 1B (upper panel), in the majority of 
the tissues tested, a single EFP1 transcript with an estimated 
size of 3.4 kb was detected. Expression of the EFP1 tran-
script was highest in liver (Figure 1B, lane 5), less promi-
nent in heart, brain, lung and kidney (Figure 1B, lanes 1, 
2, 4 and 7) and rather low in spleen and testis (Figure 1B, 
lanes 3 and 8). No EFP1 transcript could be detected in 
skeletal muscle (Figure 1B, lane 6). The housekeeping gene Cell Health and Cytoskeleton 2009:1 
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glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was 
employed as reference (Figure 1B, lower panel).
Since the mRNA expression of GAPDH was quite 
variable between tissues, we performed a densiometric 
analysis of EFP1 and GAPDH bands detected after Northern 
blot analysis in Figure 1B using ImageJ software. The graph 
bar in Figure 1C shows the expression of EFP1 normalized 
to GAPDH. The densiometric analysis revealed that the 
relative expression level of EFP1 was highest in lung and 
spleen, less prominent in testis, liver and kidney and rather 
low in brain and heart. EFP1 expression was not detected 
in skeletal muscle.
In order to investigate the expression of EFP1 in trans-
formed versus nontransformed cell lines, we performed 
semi-quantitative RT-PCR analysis with GAPDH as internal 
standard. We assayed the overall expression of EFP1 in non-
transformed rat cells (REF52.2 fibroblasts, E14-2 fetal brain 
cells) and in transformed human prostate cancer cells (PC3), 
rat glioma cells (C6), rat PNET cell lines (TZ102, TZ103 and 
TZ107), and mouse neuroblastoma cells (N2A). As shown 
in Figure 1D (lanes 1–8), all cell lines tested displayed the 
same expression level of EFP1 comparable to the uniform 
expression of the housekeeping gene GAPDH. These data 
suggested that the expression of EFP1 is not altered in the 
examined nontransformed and tumor cell lines.
Rat eFP1 is localized in the eR
To analyze the subcellular localization of rat EFP1 in 
mammalian cells, we examined C-terminally GFP- or 
Myc-tagged fusion proteins EFP1-GFP (Figure 2A, a–c) 
or EFP1-Myc (Figure 2A, d–f) in REF52.2 cells 24 h after 
transfection by confocal fluorescence microscopy. Since an 
ER localization has previously been described for the human 
ortholog of EFP1,26 we employed in our studies an anti-PDI 
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Figure  A) schematic representation of the eFP1 protein domain structure. Full length rat eFP1 (947 residues) contains a transmembrane domain (TM), two thoredoxin 
domains (a and a’), a thioredoxin-like domain (b), a coiled coil domain (CC) and a leucine zipper motive (LZ). B) expression of rat eFP1 in different tissues and cell 
lines.   A multiple tissue northern blot (Clontech) containing 2 µg of poly(A)+ RnA per lane from eight different rat tissues as indicated was probed with a cDnA fragment 
corresponding to rat eFP1 nucleotides 1583–2170 (upper panel).   The same membrane was reprobed with a 32P-labeled full-length gAPDH cDnA probe to quantify 
the eFP1 RnA expression relative to gAPDH expression (lower panel). C) Densiometric analysis of eFP1 expression normalized to gAPDH in multiple tissues.   The 
densiometric analysis of the eFP1 and gAPDH bands detected after northern blot analysis in (B) was performed using imageJ software. D) expression of eFP1 
and GAPDH in various cell lines analyzed by RT-PCR. cDNA from cell lines REF52.2, PC3, C6, E14–2, TZ102, TZ103, TZ107 and N2A (lanes 1–8) was amplified by PCR 
using conditions described under Experimental procedures.   As internal standard, the house keeping gene GAPDH was amplified in the same PCR reactions.
Abbreviations: eFP1, eF-hand binding protein 1; gAPDH, glyceraldehyde-3-phosphate dehydrogenase; RT-PCR, reverse transcriptase-polymerase chain reaction.Cell Health and Cytoskeleton 2009:1 
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antibody as marker for ER staining (Figure 2A, b and e). 
Both EFP1-GFP and EFP1-Myc (Figure 2A, a and d) were 
localized in the ER of the transfected cells and showed a 
clear colocalization with PDI (Figure 2A, b and e and merged 
images in c and f).
EFP1 is posttranslationally modified 
by n-glycosylation
When we transfected the EFP1-GFP construct into CHO 
cells and analyzed the expression of EFP1-GFP by Western 
blot analysis with a monoclonal anti-GFP antibody, we 
detected two protein bands of approximately 136 and 
155 kDa. Detailed sequence analysis of EFP1 revealed that 
the protein comprises several potential N-glycosylation sites. 
Since glycosylation can significantly alter the apparent 
molecular weight of a protein in SDS-PAGE analysis, we 
examined if glycosylation of EFP1 might be responsible 
for the two EFP1 protein variants observed by Western blot 
analysis. Hence, we subjected cell extracts from EFP1-GFP 
transfected HeLa cells to immunoprecipitation with a poly-
clonal anti-GFP antibody and treated the immunoprecipitated 
proteins with endoglycosidase H (EndoH). EndoH treatment 
specifically removes high-mannose type N-glycans which 
are typical for ER-resident proteins, but does not hydrolyze 
complex glycans that are generated by posttranslational 
modification in the Golgi apparatus. As control, we employed 
immunoprecipitated protein samples without EndoH treatment. 
The samples were analyzed by Western blotting with the 
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Figure  A) subcellular localization of eFP1 in ReF52.2 cells. ReF52.2 cells were transiently transfected with expression plasmids encoding either eFP1-gFP (a) or eFP1-Myc 
(d). 24 h post-transfection, the cells were fixed with paraformaldehyde and stained for indirect immunofluorescence microscopy with the mouse monoclonal anti-c-Myc 
antibody (d), with the rabbit polyclonal anti-PDi antibody (b and e) and with Cy3-labeled secondary antibodies. The yellow signals in the merged images (c and f) indicate 
colocalization. scale bar, 20 µm. B) n-glycosylation analysis of eFP1. HeLa cells were transfected with the eFP1-gFP expression vector and 24 h post-transfection, cell lysates 
were prepared and subjected to immunoprecipitation with the polyclonal anti-gFP antibody (lane 1).   The immunoprecipitated eFP1-gFP proteins were further treated with 
endoH (lane 3) or left untreated as control (lane 2).   Arrows indicate the positions of the 136 kDa or the 155 kDa eFP1-gFP protein. note that after endoH treatment the 
155 kDa eFP1-gFP protein band is no longer detectable. C) eFP1 catalyzes the reduction of insulin. 3.9 µM recombinant affinity purified His6-eFP1 protein (black squares) 
and His6-eFP1THX_protein (white squares) were employed in a quantitative insulin disulfide reduction assay containing 0.13 mM bovine insulin and 0.33 mM dithiothreitol in a 
final volume of 120 µl. Recombinant purified thioredoxin from E coli was included as positive control (black circles) and a sample containing only dithiothreitol served as nega-
tive control (white circles).   The rate of insulin reduction was measure spectrophotometrically at 650 nm as turbidity formation from the precipitation of free insulin B chain 
plotted against time. D) The same experiment as shown in (C) without the data obtained from the E coli thioredoxin experiments and plotted with an altered y-axis scale. 
The results are presented as mean values from three independent experiments. E)   Analysis of eFP1 expression upon eR stress. niH3T3 cells were treated with the indicated 
drugs (lanes 2–7) and with DMsO as control (lane 1). 16–24 h after treatment, the cells were harvested and the expression of eFP1 was analyzed by RT-PCR (upper panel). 
The expression of gAPDH (lower panel) and the expression of gRP78/BiP (middle panel) served as internal controls. note that the expression of eFP1 is clearly upregulated 
in niH3T3 cells treated with eR stress-inducing agents.
Abbreviations: GFP, green fluorescence protein; PDI, protein disulphide isomerase; EndoH, endoglycosidase H; DMSO, dimethyl sulfoxide; GRP78/Bip, glucose-regulated protein 
78/immunoglobulin binding protein; THX, thioredoxin.Cell Health and Cytoskeleton 2009:1 
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monoclonal anti-GFP antibody. Immunoprecipitation of 
EFP1-GFP with the anti-GFP antibody specifically precipi-
tated two proteins of about 136 and 155 kDa representing 
the two EFP1-GFP variants (Figure 2B, lane 1). When the 
immunoprecipitated proteins were treated with Endo H, the 
136 kDa EFP1-GFP protein band was detected, whereas 
the 155 kDa EFP1-GFP protein band was no longer visible 
(Figure 2B, lane 3). Thus, our results clearly demonstrated 
that EFP1 is a high mannose type-glycoprotein.
eFP1 possesses enzymatic activity
Since the C-terminal thioredoxin domain (THX II) of EFP1 
contains an active site CXXC motif, typical for members of 
the thioredoxin (Trx) family, we next wanted to examine 
whether this thioredoxin domain of EFP1 is functional. For 
this purpose, we employed recombinant affinity purified His6-
tagged EFP1 wt protein (designated His6-EFP1) and a His6-
EFP1THX- mutant carrying cysteine to serine substitutions in 
the active site CXXC motif in an insulin disulfide reduction 
assay. The quantitative assay was developed to measure the 
rate of insulin reduction spectrophotometrically at 650 nm as 
turbidity formation from the precipitation of the free insulin 
B chain.37 As control, we included recombinant purified 
thioredoxin from E. coli (denoted E. coli THX) in our experi-
ment, which has dithiol-disulfide-oxidoreductase activity 
and catalyzes the reduction of insulin by dithiothreitol. The 
recombinant His6-EFP1 wt protein (Figures 2C and D, black 
squares) indeed catalyzes the reduction of insulin disulfides, 
although the kinetic of the reaction showed a markedly slower 
rate compared to THX from E. coli (Figures 2C and D, black 
circles). That the catalytic activity of EFP1 was dependent on 
the putative active site motif CXXC in the THX II-domain of 
EFP1 was demonstrated with the recombinant His6-EFP1THX- 
mutant (Figures 2C and D, white squares) which showed 
reduced insulin disulfide reduction activity compared to the 
His6-EFP1 wt protein (Figures 2C and D, black squares). 
However, the catalytic activity of the His6-EFP1THX- mutant 
was not completely abolished compared to the control 
sample containing only dithiothreitol (Figures 2C and D, 
white circles).
Upregulation of eFP1 in niH3T3  
cells after eR stress
Because EFP1 is an ER-resident protein that possesses catalytic 
activity comparable to thioredoxin and structural similarities 
to members of the PDI family of ER chaperones, we specu-
lated that EFP1 might be involved in the ER stress response. 
To test this hypothesis, we treated NIH3T3 cells with the ER 
stress-inducing agents tunicamycin and brefeldin A, with the 
Ca2+ stress inducing agents thapsigargin and ionomycin, the 
latter also inducing ER stress. Furthermore, the cells were 
treated with the oxidative stress inductor H2O2, with stauro-
sporine (STS), which induces apoptosis independently of ER 
stress, and with DMSO as control. The expression of EFP1 
was examined by RT-PCR analysis (Figure 2E, upper panel) 
with GAPDH as internal control (Figure 2E, lower panel). 
We also determined the expression of the ER stress marker 
GRP78/BiP (Figure 2E, middle panel). Treatment of  NIH3T3 
cells with either ionomycin, tunicamycin, thapsigargin, or 
brefeldin A (Figure 2E, upper panel, lanes 2–5), clearly 
resulted in the upregulation of EFP1. In analogy to these 
findings, the expression of the ER stress marker GRP78/BiP 
was also upregulated after ionomycin, tunicamycin, thapsi-
gargin and brefeldin A treatment (Figure 2E, middle panel, 
lanes 2–5). In contrast, neither EFP1 nor GRP78/BiP expres-
sion was affected after induction of oxidative stress by H2O2 
(Figure 2E, lane 6) or after ER-independent induction of apop-
tosis by staurosporine (Figure 2E, lane 7), thus demonstrating 
that the observed upregulation of EFP1 represents a specific 
ER stress-response.
eFP1 interacts with Par-4
Since the rat EFP1 cDNA was originally isolated in a yeast 
two-hybrid analysis with Par-4 as bait, we wanted to confirm 
the interaction of full length EFP1 with Par-4, both in vitro 
and in vivo. For the in vitro binding assays, Par-4 was 
expressed as His6-tagged fusion protein in E. coli, immobi-
lized on NiNTA beads and incubated with35 S-methionine-
labeled in vitro-translated EFP1 protein. After stringent 
washing, the bound proteins were eluted from the NiNTA-
matrix and analyzed by SDS-PAGE. In order to test whether 
the complex formation of EFP1 and Par-4 was dependent 
on a functional leucine zipper of Par-4, we also employed a 
His6-tagged leucine-zipper point mutant of Par-4 (denoted 
His6-Par-4 L3A), which contained three exchanges of leucine 
residues to alanines in the coiled coil interface. As shown in 
Figure 3A, EFP1 was pulled down together with His6-Par-4 
wt (Figure 3A, lane 3) and with His6-Par-4 L3A (Figure 3A, 
lane 4), but not with NiNTA beads alone which served as 
negative control (Figure 3A, lane 2). Since equal amounts 
of EFP1 were eluted from the NiNTA-Par-4 wt and the 
NiNTA-Par-4 L3A matrixes, these results suggested that 
the interaction between EFP1 and Par-4 is not mediated by 
the leucine zipper of Par-4.
To further corroborate these findings, we performed 
dot-blot experiments with EFP1, Par-4 wt and Par-4 L3A. Cell Health and Cytoskeleton 2009:1 
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As positive control we included the novel Par-4 interaction 
partner Amida in our study, since it has been shown that 
complex formation between Par-4 and Amida requires 
a functional leucine-zipper of Par-4.21 Hence, purified 
recombinant EFP1 and Amida proteins were spotted as 
dots on nitrocellulose membranes. Bovine serum albumin 
(BSA) served as negative control (Figure 3B). Next, the 
membranes were incubated with purified recombinant Par-4 
(Figure 3B, lanes 1–3) or Par-4 L3A (Figure 3B, lanes 4–6) 
and subsequently stained with an anti-Par-4 antibody. Par-4 
wt was detected in a concentration-dependent manner on 
both the Amida and EFP1 spotted membranes (Figure  3B, 
lane 2 and 3) but no reaction with the BSA protein was 
observed (Figure 3B, lane 1). Interestingly, whereas the 
binding of Par-4 L3A to Amida was clearly reduced 
(Figure 3B, compare lanes 2 and 5), binding of Par-4 wt and 
Par-4 L3A to EFP1 was equally strong (Figure 3B, compare 
lanes 3 and 6). Thus, confirming our previous results that the 
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Figure  Analysis of eFP1 and Par-4 interaction. A) Pull-down experiment using recombinant His6-Par-4 fusion protein (lane 3) and His6-Par-4 L3A fusion protein (lane 4) 
immobilized on a ninTA matrix and in-vitro translated 35s-methionine-labeled eFP1. ninTA beads alone served as negative control (lane 2). samples were further processed 
and analyzed by SDS-PAGE and subsequent fluorography.   The input (lane 1) represents 1/10 of the material used in the binding reactions. B) Dot blot analysis of eFP1 and 
Par-4. 10–250 ng of purified recombinant His6-eFP1 protein (lanes 3 and 6), His6-Amida protein (positive control, lanes 2 and 5) and BsA (negative control, lanes 1 and 4) were 
spotted as dots on nitrocellulose membranes.   The membranes were incubated with 3 µg/ml of purified recombinant His6-Par-4 wt protein (lanes 1–3) or purified recombinant 
His6-Par-4 L3A mutant protein (lanes 4–6) and further processed as described for Western blot analysis with the monoclonal anti-Par-4 antibody. C) Coexpression of eFP1 
and Par-4. REF52.2, CHO and COS-1 cells were cotransfected with EFP1-GFP and FLAG-Par-4 expression vectors. 24 h post-transfection, the cells were fixed and stained 
with the monoclonal anti-FLAg M2 antibody and with Cy3-labeled antibodies (b, c and h). no colocalization could be detected in the eFP1-gFP/FLAg-Par-4 coexpressing 
cells (merged images in c, f, and i). scale bar, 20 µm. (D) Co-immunoprecipitation of eFP1 and Par-4. CHO cells stably expressing an eFP1-gFP fusion protein were transfected 
either with FLAg-Par-4 (lane 2) or empty FLAg-vector as control (lane 1). 24 h after transfection, the cells were metabolically labeled with [35s] methionine and the cell 
lysates subjected to immunoprecipitation with the rabbit polyclonal anti-gFP antibody.   The immunoprecipitated proteins were separated on a 7.5% sDs-PAge and analyzed 
by autoradiography.   Arrows indicate the positions of FLAg-Par-4 and the eFP1-gFP fusion proteins.
Abbreviations: BsA, bovine serum albumin; ninTA, nickel-nitrilotriacetic acid. Cell Health and Cytoskeleton 2009:1 0
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interaction of Par-4 and EFP1 does not require the leucine 
zipper of Par-4.
To verify the interaction of EFP1 and Par-4 in vivo, 
cotransfection experiments with REF52.2, CHO and COS-1 
cells were carried out with FLAG-Par-4 and EFP1-GFP. 24 h 
post-transfection, the cells were fixed, immunostained and 
analyzed by confocal fluorescence microscopy (Figure 3C). 
As expected, FLAG-Par-4 was clearly associated with actin 
filaments in REF52.2 cells and CHO cells (Figure 3C, b 
and e), whereas Par-4 was diffusely distributed in COS-1 
cells (Figure 3C, h), which lack a well organized actin cyto-
skeleton. In contrast, the EFP1-GFP construct showed no 
association with stress fibers in the FLAG-Par-4/EFP1-GFP 
coexpressing cells, but rather displayed an ER specific fluo-
rescence staining (Figure 3C, a, d and g).
We then performed co-immunoprecipitation experiments 
with CHO cells stably expressing an EFP1-GFP fusion 
protein and transfected the cells with either FLAG-Par-4 
or empty FLAG-vector as control. 24 h after transfection, 
the cells were metabolically labeled with [35S]-methionine 
and the cell lysates were subjected to immunoprecipitation 
with the rabbit polyclonal anti-GFP antibody. A protein of 
about 48 kDa representing the FLAG-Par-4 fusion protein 
was specifically coprecipitated with EFP1-GFP (Figure 3D, 
lane 2) which could not be detected in mock-transfected cells 
(Figure 3D, lane 1). In summary, our data provide strong 
evidence that EFP1 and Par-4 interact under physiological 
conditions, although no colocalization was observed by 
immunofluorescence analysis.
Coexpression of eFP1 and Par-4 leads 
to enhanced apoptosis
Since we could show a physical interaction between EFP1 
and the pro-apoptotic protein Par-4, we next asked whether 
EFP1 is also involved in Par-4-mediated apoptosis. To address 
this question, we co-transfected CHO cells with EFP1-GFP 
and FLAG-Par-4, fixed the cells 48 h post-transfection 
and stained the cells with the monoclonal anti-FLAG M2 
antibody and with DAPI to visualize nuclei. Figure 4A 
(a–d) represents a cell co-transfected with EFP1-GFP and 
FLAG-Par-4 with normal morphology, whereas Figure 4A 
(e-h) represents a cell co-transfected with EFP1-GFP and 
FLAG-Par-4 with apoptotic morphology, ie, fragmented 
nuclei, condensed chromatin, and membrane blebbing.
In order to determine the percentage of apoptotic cells 
among the EFP1 and Par-4 co-expressing cells, we trans-
fected CHO cells either with FLAG-Par-4, EFP1-GFP, 
EFP1THX--GFP or GFP-vector alone or co-transfected the cells 
with FLAG-Par-4/EFP1-GFP or FLAG-Par-4/EFP1THX--GFP. 
48 h post-transfection, the cells were fixed, immunostained 
with the monoclonal anti-FLAG M2 antibody and with DAPI 
to visualize nuclei and analyzed for morphological features 
of apoptosis. As shown in Figure 4B, the expression of the 
pro-apoptotic protein Par-4 alone resulted in induction of 
apoptosis of about 24% in CHO cells, whereas the expres-
sion of EFP1 leads to induction of apoptosis in about 10% 
of the transfected cells. Coexpression of EFP1 and Par-4 wt 
significantly increased the induction of apoptosis (about 30%, 
p  0.05), in contrast to 25% of apoptotic cells coexpress-
ing Par-4 wt and mutant EFP1THX-. Thus, indicating that the 
catalytic activity of EFP1 is required for the Par-4/EFP1-
mediated apoptosis.
siRnA oligonucleotide-mediated 
knockdown of Par-4 inhibits  
Ca2+stress-mediated apoptosis
Our findings demonstrate that Par-4 and EFP1 seem to play 
an important role in ER stress-mediated apoptosis. In order 
to corroborate these findings, we performed knockdown 
experiments in HeLa cells employing Cy3-labeled double 
stranded siRNA oligonucleotides against human Par-4. In 
order to show the specificity of the human Par-4 siRNA 
oligonucleotides, we transfected HeLa cells with 20 pmol 
human Par-4 siRNA oligonucleotides or with rat Par-4 siRNA 
oligonucleotides as a mismatch control. 48 h after transfec-
tion, the expression of endogenous Par-4 was analyzed by 
Western blotting or by confocal fluorescence microscopy 
with the polyclonal anti-Par-4 antibody. After transfection 
with the human Par-4 siRNA oligonucleotides, only a faint 
Par-4 protein band of about 40 kDa was detected (Figure 5A, 
lane 2, upper panel) compared to the strong Par-4 protein 
band in control cells (Figure 5A, lane 1, upper panel). In 
order to verify that the different amounts of Par-4 detected 
in the samples were not due to unequal protein loading, 
immunostaining of the same membrane was performed 
with an α-tubulin antibody (Figure 5A, lower panel). The 
specificity of the Cy3-labeled double stranded human 
Par-4 siRNA oligonucleotides was further confirmed by 
confocal fluorescence microscopy (Figure 5 B). In control 
cells, a strong fluorescence staining was detected with the 
polyclonal anti-Par-4 antibody (Figure 5B, a), in contrast to 
the human Par-4 siRNA oligonucleotide transfected cells 
(Figure 5B, b).
We next examined the effect of the siRNA oligonucle-
otide-mediated knockdown of endogenous Par-4 on ER Cell Health and Cytoskeleton 2009:1 
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stress-mediated apoptosis. Hence, we transfected HeLa cells 
with either human Par-4 siRNA or rat Par-4 siRNA as control, 
and treated the cells 48 h after transfection with agents induc-
ing ER stress (ionomycin, thapsigargin, tunicamycin), with 
agents inducing ER stress independent apoptosis (etoposide 
and staurosporine) or with DMSO as control. Cells were fixed 
and stained with the rabbit polyclonal anti-Par-4 antibody and 
with DAPI to visualize nuclei. The percentage of apoptotic 
cells that showed fragmented nuclei, condensed chromatin 
and membrane blebbing was determined by fluorescence 
microscopy. As depicted in Figure 5C, treatment of HeLa 
cells with ionomycin induced apoptosis in about 17% of 
the cells (Figure 5C, white column), whereas the siRNA 
oligonucleotide-mediated knockdown of Par-4 resulted in 
3% apoptotic cells (Figure 5C, black column). The percent-
age of apoptotic cells after treatment with thapsigargin of 
about 30% (Figure 5C, white column) was also significantly 
decreased to approximately 15% after siRNA-mediated Par-4 
knockdown (Figure 5C, black column) (p  0.01 for both 
agents in a two-tailed paired t-test). In contrast, no significant 
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Figure  Apoptosis induction in CHO cells upon overexpression of eFP1-gFP and FLAg-Par-4. A) CHO cells were co-transfected with FLAg-Par-4 and eFP1-gFP. 48 h 
post-transfection, the cells were fixed, stained with the monoclonal anti-FLAG M2 antibody (a and e) and with DAPI (c and g) to visualize nuclei. (a–d) Representative cell 
co-transfected with FLAg-Par-4 and eFP1-gFP showing normal morphology and (e–h) representative cell co-transfected with FLAg-Par-4 and eFP1-gFP showing apoptotic 
morphology, ie, fragmented nuclei, condensed chromatin and membrane blebbing. scale bar, 10 µm. B) Quantitative analysis of apoptosis induction upon coexpression of 
eFP1-gFP and FLAg-Par-4. CHO cells were transiently transfected either with eFP1-gFP, eFP1THX—gFP, FLAg-Par-4 or gFP-vector alone (control) or co-transfected with 
FLAg-Par-4/eFP1-gFP or FLAg-Par-4/eFP1THX—GFP. 48 h post-transfection, the cells were fixed, stained with the monoclonal anti-FLAG M2 antibody and with DAPI to visualize 
nuclei. The percentage of cells that showed apoptotic morphology (ie, fragmented nuclei, condensed chromatin and membrane blebbing; see also A, e–h) was determined 
among the transfected cells by fluorescence microscopy counting 100 to 200 positive cells in each experiment.   The graph represents the mean values and standard errors 
from five independent experiments. Note that the difference in the percentage of apoptotic cells upon expression of Par-4 alone and coexpression of Par-4/EFP1 (marked by 
an asterisk) is statistically significant (p = 0.037).
Abbreviations: DAPi, 4, 6-diamidino-2-phenylindole; THX, thioredoxin. Cell Health and Cytoskeleton 2009:1 
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decrease in apoptosis induction was observed after treatment 
of the cells with tunicamycin, etoposide or staurosporine after 
human Par-4 siRNA oligonucleotide transfection (Figure 5C, 
black columns), thus demonstrating that Par-4 might play an 
important role in Ca2+ stress-mediated apoptosis.
Discussion
In the present study, we report on the functional characteriza-
tion of the rat ortholog of EFP1 and show that EFP1 is a novel 
interaction partner of the pro-apoptotic protein Par-4.
The rat EFP1 protein shares 79% similarity with the 
human EFP1 protein, with the highest sequence identity 
between amino acids 51–304 and 564–767. According to 
secondary structure predictions, the first conserved region 
of rat EFP1 comprises a putative thioredoxin domain with 
an inactive catalytic site and an adjacent region that is in 
good agreement with the thioredoxin fold.40 The second 
conserved region of the rat EFP1 protein also contains a 
putative thioredoxin domain but harbors a catalytically active 
CXXC motif (787CGFC790). The presence of two putative 
thioredoxin domains and the similarity in protein domain 
structure suggest that EFP1 is a member of the PDI family, 
a growing family of ER proteins that display isomerase, 
chaperone and calcium binding properties.41,42 The founding 
member, PDI, possesses the domain structure a-b-b’-a’-c, 
with a and a’ representing the catalytically active thioredoxin 
domains, b and b’ the thioredoxin-like domains and c the 
calcium binding domain. The b’ domain has been impli-
cated in substrate binding, whereas the b domain appears 
to have a rather structural function.41 For full catalytic 
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Figure  effect of siRnA oligonucleotide-mediated knockdown of Par-4 on eR stress-mediated apoptosis. A) HeLa cells were transfected with either Cy3-labeled double 
stranded human Par-4 siRnA oligonucleotides (lane 2) or with rat Par-4 siRnA oligonucleotides as a mismatch control. (lane 1). 48 h after transfection cell lysates were 
subjected to sDs-PAge and Western blot analysis with the rabbit polyclonal anti-Par-4 antibody (upper panel) or with the mouse monoclonal anti-α-tubulin antibody as loading 
control (lower panel). B) HeLa cells were either transfected with 20 pmol of human Par-4 siRnA olgonucleotides (b) or with rat Par-4 siRnA oligonucleotides as a mismatch 
control (a). 48 h after transfection, cells were fixed with formaldehyde and stained with the rabbit polyclonal anti-Par-4 antibody. Scale bar, 10 µm. C) HeLa cells were transfected 
with either human Par-4 siRnA oligonucleotides (black columns) or with rat Par-4 siRnA oligonucleotides as a mismatch control (white columns). 48 h after transfection 
cells were exposed to different apoptotic stimuli (ionomycin, thapsigargin, tunicamycin, etoposide or staurosporine) and as a control with DMsO. 16–24 h after treatment the 
cells were fixed and stained with the rabbit polyclonal anti-Par-4 antibody and with DAPI to visualize nuclei.   The percentage of cells that showed apoptotic morphology (ie, 
fragmented nuclei, condensed chromatin and membrane blebbing) was determined by fluorescence microscopy counting 100 to 200 cells in each experiment exhibiting no 
Par-4 expression. The graph represents the mean values and standard errors from three independent experiments. note that the decrease in the percentage of apoptotic cells 
after siRNA-mediated knockdown of Par-4 is statistically significant for ionomycin (p = 0.0043) and thapsigargin (p = 0.0019) (marked by asterisks).
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activity, all thioredoxin-like domains of PDI are required.43 
In comparison, rat EFP1 contains the domain structure a-b-
x-a’-CC/LZ, where CC/LZ represents the coiled coil and the 
leucine zipper domain and x an uncharacterized domain or 
a linker region (Figure 1A). Although no high sequence or 
structural similarities were identified between the x domain 
of rat EFP1 and the b’ domain of PDI, the similar domain 
position suggests a possible function in substrate binding. 
Some of the PDI family members, like ERp29, possess a 
C-terminal alpha helical D domain that seems to be involved 
in substrate processing.42,44 However, the C-terminal coiled 
coil domain of rat EFP1 shows no sequence identity with the 
D-domain of the other PDI family members, arguing that this 
protein-protein interaction domain is unique for EFP1.
Analysis of the expression of EFP1 at the transcriptional 
level revealed a ubiquitous expression in various rat tissues, 
whereas no EFP1 transcript could be detected in rat skeletal 
muscle. Additionally, EFP1 is ubiquitously expressed in sev-
eral tumor cell lines. Ectopic expression and immunostaining 
of rat EFP1-GFP and EFP1-Myc fusion proteins showed that 
the proteins reside in the ER as it has been demonstrated 
for the human ortholog.26 Unfortunately, no specific EFP1 
antibodies are available to demonstrate the subcellular 
localization of the endogenous EFP1 protein. However, the 
presence of an ER signal anchor and the structural similarities 
with the members of the PDI protein family supports the ER 
distribution of the EFP1 protein. Furthermore, by employing 
an insulin disulfide reduction assay, we demonstrated that 
the purified recombinant EFP1 protein possesses catalytic 
activity and that the catalytic activity is dependent on the 
active site motif 787CGFC790 located in the second thioredoxin 
domain of EFP1. The kinetics of the reaction with EFP1 
showed a slower rate compared to recombinant purified thio-
redoxin from E. coli. Yet, it has to be taken into consideration 
that EFP1, like other thioredoxin-related proteins, might be 
involved in various redox regulations (eg, oxidation, isom-
erization). The catalytic activity of EFP1 was not completely 
abolished after substitution of the cysteine residues to serine 
residues in the active site CXXC motif; therefore it is likely 
that the catalytic activity of EFP1 only partially involves 
reduction activity. Our results are in good agreement with 
a previous report of Horibe and colleagues,45 showing that 
the PDI family member PDIr retained over 50% of oxidative 
refolding activity towards α1-antitrypsin after exchanging all 
six catalytic site cysteine to serine residues.
We demonstrate in this study that EFP1 is a glycoprotein 
and that the glycosylation is of the high mannose type typi-
cal for ER-resident proteins. We do not know whether the 
highly glycosylated 155-kDa form of EFP1 represents the 
mature active protein. It has been reported that the highly 
glycosylated 190-kDa form of the EFP1 interaction partner 
Duox corresponds to the mature active protein expressed at 
the plasma membrane and that the high mannose 180-kDa 
form corresponds to the immature inactive protein which 
resides in the ER.26 Likewise, the ectopically expressed EFP1 
protein could represent a less active protein compared to the 
endogenous EFP1 protein.
The expression of EFP1 was upregulated at the 
transcriptional level upon treatment of cells with agents that 
induce ER stress, but not by agents that induce oxidative 
stress or ER-independent apoptosis. Thus, EFP1 is specifi-
cally upregulated during ER stress, as it has been shown for 
a number of ER chaperones, including many members of the 
PDI family.46 Our findings suggest that EFP1 may function 
as a cell-protective enzyme and corroborate the assumption 
that EFP1 is a member of the PDI family. Unfortunately, 
no specific EFP1 antibodies are available to examine the 
upregulation of EFP1 after ER stress at the protein level. 
Clearly, this issue requires further investigation.
We have identified the rat ortholog of EFP1 in a yeast 
two-hybrid screen in search for new interaction partners 
of Par-4 that might serve as regulators or targets in Par-4-
mediated apoptosis. The interaction between Par-4 and EFP1 
was confirmed by pull-down experiments, dot blot analysis 
and co-immunoprecipitation experiments. These experi-
ments corroborated a physical interaction of both proteins, 
although ectopically expressed EFP1-GFP and FLAG-Par-4 
did not colocalize in the transfected cells. It has been demon-
strated that many members of the PDI family and other ER 
proteins like calreticulin are not only localized in the ER 
but also in non-ER locations.47 PDI itself has been found in 
the nucleus48 as well as outside of the cell, either attached 
to the cell surface or in a secreted form.49 Overexpressed 
ERp57 was shown to be secreted from cultured cells50 and 
has been detected both in the cytosol51 and in the nucleus.48 
The mechanism by which proteins of the PDI family can 
escape from the ER is unknown. It is therefore possible that 
by a similar mechanism, EFP1 can escape from the ER and 
interact with Par-4 in the cytoplasm to control the function 
of Par-4 after induction of ER stress.
Despite the well-established apoptotic action of Par-4, our 
understanding of molecular mechanisms controlling Par-4 
function is limited. To date, only two regulatory mechanisms 
are known: the upregulation of Par-4 gene transcription,20,52 
and the phosphorylation within the 59-residue core region, 
termed selective for apoptosis induction in cancer cells (SAC) Cell Health and Cytoskeleton 2009:1 
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domain53 at the critical phosphorylation site T164/T155 
(human and rat amino acid sequence, respectively). However, 
other regulatory mechanisms are likely to exist, since Par-4 is 
expressed in various tissues and cell lines without inducing 
apoptosis or sensitizing the cells for apoptosis. The novel 
Par-4 interaction partner EFP1 is a good candidate to regulate 
the function of Par-4 since i) coexpression of Par-4 and EFP1 
in CHO cells resulted in enhanced Par-4-mediated apoptosis 
and ii) EFP1/Par-4-mediated apoptosis is dependent on the 
catalytic activity of EFP1. How EFP1 exerts its regulatory 
function on Par-4 remains elusive. It is tempting to speculate 
that EFP1 might function as a molecular chaperone or disul-
fide isomerase which can induce a conformational change of 
the Par-4 protein resulting in enhanced Par-4 activity. Indeed, 
the amino acid sequence of the rat Par-4 protein contains three 
cysteine residues at the position 82, 103, and 165 which are 
able to form disulfide bonds to stabilize the tertiary and/or 
quaternary structure of the protein.
As a potential regulator of Par-4, EFP1 provides a link 
between ER stress and Par-4-induced apoptosis. Par-4 has 
been suggested to play a significant role in ER stress-induced 
apoptosis in Alzheimer’s disease,19 and deregulated expres-
sion of Par-4 has been implicated not only in Alzheimer’s 
disease,54–57 but also in amyotrophic lateral sclerosis (ALS), 
Parkinson’s disease and ischemic neuronal death.58–61 Fur-
thermore, we could show in this study that Par-4 might play 
an important role in Ca2+ stress-mediated apoptosis, since 
the induction of apoptosis in the ionomycin and thapsigargin 
treated cells were significantly decreased after siRNA oligo-
nucleotide-mediated knockdown of Par-4. That the siRNA 
oligonucleotide-mediated knockdown of Par-4 had no effect 
on apoptosis induction after treatment of the cells with the 
glycosylation inhibitor tunicamycin might be explained by 
the fact that EFP1 is a glycoprotein and thus, tunicamycin 
might hamper the function of EFP1 and Par-4.
Therefore, we propose a hypothetical model how EFP1 
and Par-4 might determine the cell fate during ER stress 
(see Figure 6). In the presence of low Par-4 levels, EFP1 
may act as a molecular chaperone or disulfide isomerase and 
contribute to restore the ER function (left part of Figure 6). 
If the ER stress response fails to restore the ER function, a 
disturbed calcium homeostasis (“Ca2+ stress”) might be the 
consequence, leading to transcriptional upregulation of Par-4 
as has been shown by Sells and colleagues and by Hsu and 
colleagues20,52 and to the induction of apoptosis. In the pres-
ence of high Par-4 levels, EFP1 may function as an activator 
of Par-4, thus enhancing Par-4-mediated apoptosis (right part 
of Figure 6). According to our model, Par-4 itself is not fully 
active until ER stress and upregulation of EFP1 occurs. Once 
fully activated by EFP1, Par-4 induces apoptosis.
By identifying EFP1 as a novel interaction partner and 
potential regulator of Par-4, we provide a missing link 
between Par-4 and ER stress, elevated intracellular calcium 
levels, and the induction of apoptosis. Detailed analysis of the 
EFP1-Par-4 interplay might therefore yield valuable insights 
into the regulatory mechanisms of ER stress and apoptosis.
Acknowledgments
We thank Reinhild Brinker for excellent technical assistance 
and KH Scheidtmann for helpful discussions. This study was 
supported by the Deutsche Krebshilfe, Dr Mildred Scheel 
Stiftung (106365) to UP. The authors report no conflicts of 
interest in this work.
References
  1.  Yoshida H, Haze K, Yanagi H, Yura T, Mori K. Identification of the 
cis-acting endoplasmic reticulum stress response element responsible 
for transcriptional induction of mammalian glucose-regulated proteins. 
Involvement of basic leucine zipper transcription factors. J Biol Chem. 
1998;273(50):33741–33749.
  2.  Haze K, Yoshida H, Yanagi H, Yura T, Mori K. Mammalian transcription 
factor ATF6 is synthesized as a transmembrane protein and activated 
by proteolysis in response to endoplasmic reticulum stress. Mol Biol 
Cell. 1999;10(11):3787–3799.
  3.  Wang Y, Shen J, Arenzana N, et al. Activation of ATF6 and an ATF6 
DNA binding site by the endoplasmic reticulum stress response. J Biol 
Chem. 2000;275(35):27013–27020.
  4.  Schröder M, Kaufman RJ. ER stress and the unfolded protein response. 
Mutat Res. 2005;569(1–2):29–63.
ER stress Ca2+ stress
Par-4
Par-4
-inactive-
-active-
apoptosis
function
EFP1
restoration of ER
Figure  Model for the function of eFP1 and Par-4 during eR stress. eFP1 is upregulated 
as part of the eR stress response and contributes to restore the eR function (left part). 
if the eR stress response fails, an elevated calcium level (“Ca2+ stress”) might lead to 
a transcriptional upregulation of Par-4 (right part). Hence, eFP1 may function as an 
activator of Par-4, thus enhancing Par-4-mediated apoptosis.
Abbreviation: eR, endoplasmatic reticulum.Cell Health and Cytoskeleton 2009:1 
The novel Par-4 interaction partner eFP1 is upregulated during eR stress Dovepress
submit your manuscript | www.dovepress.com
Dovepress 
  5.  Sitia R, Molteni SN. Stress, protein (mis)folding, and signaling: the 
redox connection. Sci STKE. 2004;2004(239):pe27.
  6.  Lucero HA, Lebeche D, Kaminer B. ERcalcistorin/protein-disulfide 
isomerase acts as a calcium storage protein in the endoplasmic reticulum 
of a living cell. Comparison with calreticulin and calsequestrin. J Biol 
Chem. 1998;273(16):9857–9863.
  7.  Van PN, Peter F, Soling HD. Four intracisternal calcium-binding glyco-
proteins from rat liver microsomes with high affinity for calcium. No 
indication for calsequestrin-like proteins in inositol 1,4,5-trisphosphate-
sensitive calcium sequestering rat liver vesicles. J Biol Chem. 1989; 
264(29):17494–17501.
  8.  Lievremont JP, Rizzuto R, Hendershot L, Meldolesi J. BiP, a major 
chaperone protein of the endoplasmic reticulum lumen, plays a direct 
and important role in the storage of the rapidly exchanging pool of 
Ca2+. J Biol Chem. 1997;272(49):30873–30879.
  9.  Rao RV, Ellerby HM, Bredesen DE. Coupling endoplasmic reticulum 
stress to the cell death program. Cell Death Differ. 2004;11(4):372–380.
10.  Cryns V, Yuan J. Proteases to die for. Genes Dev. 1998;12(11):1551–1570.
11.  Hitomi J, Katayama T, Eguchi Y, et al. Involvement of caspase-4 in 
endoplasmic reticulum stress-induced apoptosis and Abeta-induced 
cell death. J Cell Biol. 2004;165(3):347–356.
12.  Nakagawa T, Zhu H, Morishima N, et al. Caspase-12 mediates endo-
plasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-beta. 
Nature. 2000;403(6765):98–103.
13.  Jimbo A, Fujita E, Kouroku Y, et al. ER stress induces caspase-8 
activation, stimulating cytochrome c release and caspase-9 activation. 
Exp Cell Res. 2003;283(2):156–166.
14.  Rao RV, Hermel E, Castro-Obregon S, et al. Coupling endoplasmic 
reticulum stress to the cell death program. Mechanism of caspase 
activation. J Biol Chem. 2001;276(36):33869–33874.
15.  Obeng EA, Boise LH. Caspase-12 and caspase-4 are not required for 
caspase-dependent endoplasmic reticulum stress-induced apoptosis. 
J Biol Chem. 2005;280(33):29578–29587.
16.  Wang XZ, Lawson B, Brewer JW, et al. Signals from the stressed 
endoplasmic reticulum induce C/EBP-homologous protein (CHOP/
GADD153). Mol Cell Biol. 1996;16(8):4273–4280.
17.  McCullough KD, Martindale JL, Klotz LO, Aw TY, Holbrook NJ. 
Gadd153 sensitizes cells to endoplasmic reticulum stress by down-
regulating Bcl2 and perturbing the cellular redox state. Mol Cell Biol. 
2001;21(4):1249–1259.
18.  Mohamad N, Gutierrez A, Nunez M, et al. Mitochondrial apoptotic 
pathways. Biocell. 2005;29(2):149–161.
19.  Mattson MP, Gary DS, Chan SL, Duan W. Perturbed endoplasmic reticu-
lum function, synaptic apoptosis and the pathogenesis of Alzheimer’s 
disease. Biochem Soc Symp. 2001; (67):151–162.
20.  Sells SF, Wood DP, Jr, Joshi-Barve SS, et al. Commonality of the gene 
programs induced by effectors of apoptosis in androgen-dependent and -
independent prostate cells. Cell Growth Differ. 1994;5(4):457–466.
21.  Boosen M, Vetterkind S, Koplin A, Illenberger S, Preuss U. Par-4-
mediated recruitment of Amida to the actin cytoskeleton leads to the 
induction of apoptosis. Exp Cell Res. 2005;311(2):177–191.
22.  Page G, Kögel D, Rangnekar V, Scheidtmann KH. Interaction part-
ners of Dlk/ZIP kinase: co-expression of Dlk/ZIP kinase and Par-4 
results in cytoplasmic retention and apoptosis. Oncogene. 1999;18(51): 
7265–7273.
23.  Vetterkind S, Illenberger S, Kubicek J, et al. Binding of Par-4 to the 
actin cytoskeleton is essential for Par-4/Dlk-mediated apoptosis. Exp 
Cell Res. 2005;305(2):392–408.
24.  Cheema SK, Mishra SK, Rangnekar VM, et al. Par-4 transcriptionally 
regulates Bcl-2 through a WT1-binding site on the bcl-2 promoter. 
J Biol Chem. 2003;278(22):19995–20005.
25.  Goswami A, Burikhanov R, de Thonel A et al. Binding and phosphory-
lation of par-4 by akt is essential for cancer cell survival. Mol Cell. 
2005;20(1):33–44.
26.  Wang D, De Deken X, Milenkovic M, et al. Identification of a novel 
partner of duox: EFP1, a thioredoxin-related protein. J Biol Chem. 
2005;280(4):3096–3103.
27.  Klawitz I, Preuss U, Scheidtmann KH. Interaction of SV40 large 
T antigen with components of the nucleo/cytoskeleton. Int J Oncol. 
2001;19(6):1325–1332.
28.  Short JM, Fernandez JM, Sorge JA, Huse WD. Lambda ZAP: a bacterio-
phage lambda expression vector with in vivo excision properties. 
Nucleic Acids Res. 1988;16(15):7583–7600.
29.  Sells SF, Han SS, Muthukkumar S, et al. Expression and function of 
the leucine zipper protein Par-4 in apoptosis. Mol Cell Biol. 1997; 
17(7):3823–3832.
30.  Chenna R, Sugawara H, Koike T, et al. Multiple sequence alignment 
with the Clustal series of programs. Nucleic Acids Res. 2003;31(13): 
3497–3500.
31.  Rost B, Yachdav G, Liu J. The PredictProtein server. Nucleic Acids 
Res. 2004;32(Web Server issue):W321–326.
32.  Berger B, Wilson DB, Wolf E, et al. Predicting coiled coils by use 
of pairwise residue correlations. Proc Natl Acad Sci U S A. 1995; 
92(18):8259–8263.
33.  Horton P, Nakai K. Better prediction of protein cellular localization 
sites with the k nearest neighbors classifier. Proc Int Conf Intell Syst 
Mol Biol. 1997;5:147–152.
34.  Blom N, Gammeltoft S, Brunak S. Sequence and structure-based 
prediction of eukaryotic protein phosphorylation sites. J Mol Biol. 
1999;294(5):1351–1362.
35.  Bendtsen JD, Nielsen H, von Heijne G, Brunak S. Improved prediction 
of signal peptides: SignalP 3.0. J Mol Biol. 2004;340(4):783–795.
36.  Kawai T, Akira S, Reed JC. ZIP kinase triggers apoptosis from nuclear 
PML oncogenic domains. Mol Cell Biol. 2003;23(17):6174–6186.
37.  Holmgren A. Thioredoxin catalyzes the reduction of insulin disulfides 
by dithiothreitol and dihydrolipoamide. J Biol Chem. 1979;254(19): 
9627–9632.
38.  Kappler R, Pietsch T, Weggen S, Wiestler OD, Scherthan H. 
Chromosomal imbalances and DNA amplifications in SV40 large 
T antigen-induced primitive neuroectodermal tumor cell lines of the 
rat. Carcinogenesis. 1999;20(8):1433–1438.
39.  Martin JL. Thioredoxin – a fold for all reasons. Structure. 1995;3(3): 
245–250.
40.  Holmgren A, Soderberg BO, Eklund H, Branden CI. Three-dimensional 
structure of Escherichia coli thioredoxin-S2 to 2.8 A resolution. Proc 
Natl Acad Sci U S A. 1975;72(6):2305–2309.
41.  Ellgaard L, Ruddock LW. The human protein disulphide isomerase 
family: substrate interactions and functional properties. EMBO Rep. 
2005;6(1):28–32.
42.  Ferrari DM, Soling HD. The protein disulphide-isomerase family: 
unravelling a string of folds. Biochem J. 1999;339 ( Pt 1):1–10.
43.  Darby NJ, Penka E, Vincentelli R. The multi-domain structure of protein 
disulfide isomerase is essential for high catalytic efficiency. J Mol Biol. 
1998;276(1):239–247.
44.  Barnewitz K, Guo C, Sevvana M, et al. Mapping of a substrate binding 
site in the protein disulfide isomerase-related chaperone wind based 
on protein function and crystal structure. J Biol Chem. 2004;279(38): 
39829–39837.
45.  Horibe T, Gomi M, Iguchi D, et al. Different contributions of the 
three CXXC motifs of human protein-disulfide isomerase-related 
protein to isomerase activity and oxidative refolding. J Biol Chem. 
2004;279(6):4604–4611.
46.  Boyce M, Yuan J. Cellular response to endoplasmic reticulum stress: 
a matter of life or death. Cell Death Differ. 2006;13(3):363–373.
47.  Turano C, Coppari S, Altieri F, Ferraro A. Proteins of the PDI 
family: unpredicted non-ER locations and functions. J Cell Physiol. 
2002;193(2):154–163.
48.  Gerner C, Holzmann K, Meissner M, et al. Reassembling proteins and 
chaperones in human nuclear matrix protein fractions. J Cell Biochem. 
1999;74(2):145–151.
49.  Terada K, Manchikalapudi P, Noiva R, et al. Secretion, surface 
localization, turnover, and steady state expression of protein disul-
fide isomerase in rat hepatocytes. J Biol Chem. 1995;270(35): 
20410–20416.Cell Health and Cytoskeleton 2009:1
Cell Health and Cytoskeleton
Publish your work in this journal
Submit your manuscript here: http://www.dovepress.com/cell-health-and-cytoskeleton-journal
Cell Health and Cytoskeleton is an international, peer-reviewed open 
access journal focusing on all aspects of cell structure and function 
contributing to normal physiology and cell health and exploring the 
pathogenesis of cell dysfunction leading to adverse conditions and disease 
in the organism. The journal welcomes papers covering original research, 
basic science, reviews and evaluations, guidelines, expert opinion and 
commentary, case reports and extended reports. The manuscript manage-
ment system is completely online and includes a very quick and fair peer-
review system, which is all easy to use. Visit http://www.dovepress.com/ 
testimonials.php to read real quotes from published authors.

Appel et al Dovepress
submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
50.  Hirano N, Shibasaki F, Sakai R, et al. Molecular cloning of the human 
glucose-regulated protein ERp57/GRP58, a thiol-dependent reductase. 
Identification of its secretory form and inducible expression by the 
oncogenic transformation. Eur J Biochem. 1995;234(1):336–342.
51.  Lewis MJ, Mazzarella RA, Green M. Structure and assembly of the 
endoplasmic reticulum: biosynthesis and intracellular sorting of ERp61, 
ERp59, and ERp49, three protein components of murine endoplasmic 
reticulum. Arch Biochem Biophys. 1986;245(2):389–403.
52.  Hsu SC, Kirschenbaum F, Miller J, Cordell B, McCarthy JV. Structural 
and functional characterization of the upstream regulatory region of 
the human gene encoding prostate apoptosis response factor-4. Gene. 
2002;295(1):109–116.
53.  Gurumurthy S, Goswami A, Vasudevan KM, Rangnekar VM. Phos-
phorylation of Par-4 by protein kinase A is critical for apoptosis. Mol 
Cell Biol. 2005;25(3):1146–1161.
54.  Xie J, Chang X, Zhang X, Guo Q. Aberrant induction of Par-4 is 
involved in apoptosis of hippocampal neurons in presenilin-1 M146V 
mutant knock-in mice. Brain Res. 2001;915(1):1–10.
55.  Xie J, Guo Q. PAR-4 is involved in regulation of beta-secretase 
cleavage of the Alzheimer amyloid precursor protein. J Biol Chem. 
2005;280(14):13824–13832.
56.  Guo Q, Fu W, Xie J, et al. Par-4 is a mediator of neuronal degeneration 
associated with the pathogenesis of Alzheimer disease. Nat Med. 1998; 
4(8):957–962.
57.  Guo Q, Xie J. AATF inhibits aberrant production of amyloid beta 
peptide 1–42 by interacting directly with Par-4. J Biol Chem. 2004; 
279(6):4596–4603.
58.  Xie J, Awad KS, Guo Q. RNAi knockdown of Par-4 inhibits neuro-
synaptic degeneration in ALS-linked mice. J Neurochem. 2005;92(1): 
59–71.
59.  Pedersen WA, Luo H, Kruman I, Kasarskis E, Mattson MP. The 
prostate apoptosis response-4 protein participates in motor neuron 
degeneration in amyotrophic lateral sclerosis. FASEB J. 2000;14(7): 
913–924.
60.  Culmsee C, Zhu Y, Krieglstein J, Mattson MP. Evidence for the involve-
ment of Par-4 in ischemic neuron cell death. J Cereb Blood Flow Metab. 
2001;21(4):334–343.
61.  Duan W, Zhang Z, Gash DM, Mattson MP. Participation of pros-
tate apoptosis response-4 in degeneration of dopaminergic neu-
rons in models of Parkinson’s disease. Ann Neurol. 1999;46(4): 
587–597.